Tag Archives: limited distribution

Elixir Launches a Specialty Generic Program

Elixir, a wholly owned subsidiary of Rite Aid, recently announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022

argenx SE Selects Soleo Health as a Limited Distribution Partner for VYVGART

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, recently announced it was selected as a limited distribution partner for VYVGART

AVEO Oncology’s Limited Specialty Pharmacy Distribution Network for Fotivda Selected

Biologics by McKesson and Onco360 continue to solidify their positions as market-leading specialty pharmacy providers of oncology drugs

Soleo Health Strengthens Limited Distribution Drug Capabilities

Soleo Health has developed limited distribution networks by leveraging SoleMetrics ability to collect and deliver real-world, insightful data regarding a drug’s clinical capabilities, derived from its patients

Maxor Specialty Pharmacy Reorganizes

Maxor Specialty Pharmacy has a focus on pulmonary disease

Limited Distribution Networks

Limited Distribution Networks growth continues as Specialty Pharmacies compete to be chosen to distribute specialty pharmaceuticals. AMI’s report, Distribution Decision-Making for Specialty Drugs, found that Pharmaceutical manufacturers typically develop a product-specific distribution strategy dependent on company-specific criteria when bringing a new specialty drug to the market. Pharmaceutical manufacturers consider approximately 100-150 different specialty pharmacies (SPs) […]

Contracting With Specialty Pharmacies (SPs) At Your Own Peril

How a company works with and contracts with SPs will have to be rethought as a result of the initial Department of Justice (DoJ) settlement with BioScrip and ongoing investigation of Novartis in their marketing practices. When Novartis launched Exjade, it created a limited distribution network, including BioScrip and two other specialty pharmacies selected by […]

Onco360 to distribute Gilead Sciences’ Zydelig

Onco360 recently announced that it has been selected to be part of the limited network to distribute Gilead Sciences’ Zydelig (idelalisib) tablets. Onco360 is one of the nation’s fastest-growing independent Oncology Pharmacy and Clinical Support Services companies. It will now be part of the highly limited Specialty Pharmacy network of Zydelig tablets, which has just […]